As of 2026-02-07, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (3.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -529.1%.
The range of the Relative Valuation is (1.49) - (5.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.6x - 14.2x | 8.9x |
| Forward P/E multiples | 3.6x - 14.4x | 9.0x |
| Fair Price | (1.49) - (5.91) | (3.72) |
| Upside | -272.6% - -782.8% | -529.1% |
| Date | P/E |